Form Type: 4

SEC EDGAR Link
Accession Number:0001367644-23-000105
Date:2023-05-25
Issuer: EMERGENT BIOSOLUTIONS INC. (EBS)
Original Submission Date:

Reporting Person:

KATKIN KEITH
400 PROFESSIONAL DRIVE
SUITE 400 GAITHERSBURG, MD 20879

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2023-05-25 A 33,847 a $0.00 42,442 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. these restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. each restricted stock unit represents the right of the reporting person to receive one share of common stock of emergent biosolutions inc., subject to adjustment as provided in the grant agreement.
WhaleWisdom Logo

Elevate your investments